Quarterly ResultMay 7, 2026, 04:24 PM
Alpha Teknova Q1 Revenue Up 13.1% to $11.1M; Net Loss Narrows to $4.6M
AI Summary
Alpha Teknova reported a 13.1% increase in Q1 2026 revenue to $11.1 million, with net loss narrowing to $4.6 million from $4.65 million in the prior year. The company also saw an improvement in loss from operations, which decreased by 13.4% to $4.3 million. Clinical Solutions revenue significantly grew by 84.6% to $2.1 million, while cash used in operating activities decreased by 18.1%. The company remains in compliance with its debt covenants.
Key Highlights
- Q1 2026 revenue increased 13.1% to $11.077 million from $9.795 million year-over-year.
- Net loss narrowed to $4.555 million ($0.08 per share) from $4.645 million ($0.09 per share) YoY.
- Loss from operations improved 13.4% to $4.298 million compared to $4.964 million year-over-year.
- Clinical Solutions revenue surged 84.6% to $2.145 million in Q1 2026.
- Lab Essentials revenue grew 3.4% to $8.395 million in Q1 2026.
- Cash used in operating activities decreased 18.1% to $3.359 million from $4.103 million YoY.
- Company maintained compliance with all financial covenants under its long-term debt agreement.
- Cash and cash equivalents at period end were $4.306 million.
Price Impact
More from TKNO